Clinical Trials on BCMA-CD3 Bispecific
Total 1391 results
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCD30-Positive Diffuse Large B-Cell Lymphoma | CD30 Positive Primary Mediastinal Large B-cell Lymphoma | CD30-Positive Gray Zone LymphomaUnited States
-
University of East AngliaUniversity of Hertfordshire; London South Bank University; Health Education England... and other collaboratorsCompleted
-
National Taipei University of Nursing and Health...Cheng-Hsin General HospitalCompletedProstate-Specific AntigenTaiwan
-
University of PennsylvaniaCarnegie Mellon UniversityCompletedNot Condition-specific
-
NYU Langone HealthNew York City Health and Hospitals CorporationCompleted
-
Bamrasnaradura Infectious Diseases InstituteThai Red Cross AIDS Research Centre; Clinical Research Collaborative NetworkCompletedEffectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityTreatment Failure, HIV or AIDS | CD4 Cell CountsThailand
-
Instituto Nacional de Ciencias Medicas y Nutricion...SuspendedHIV-1-infection | Immune Deficiency | CD4+ T Lymphocytopenia | Immuno-senescenceMexico
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawnUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
Mashhad University of Medical SciencesTerminatedInteractive CD-based Education
-
First People's Hospital of ChenzhouNot yet recruiting
-
University of California, San FranciscoCompleted
-
University of SouthamptonCompletedPatient Specific Computational ModelingUnited Kingdom
-
University of ChicagoTerminatedElevated Prostate Specific AntigenUnited States
-
University of CologneUnknownCD30 Positive Cutaneous T Cell Lymphoma | CD30 Positive Transformed Mycosis FungoidesGermany
-
Charles Darwin UniversityRecruiting
-
Finch Research and Development LLC.Medpace, Inc.CompletedClostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal TransplantUnited States, Canada
-
Universitat Jaume IUniversidad de Zaragoza; University of Seville; Universidad Rey Juan CarlosCompleted
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Hospices Civils de LyonRecruitingClinical Dementia Rating (CDR) From the Analysis of Medical Record | Clinical Dementia Rating (CDR) Face-to-face Interview With the PatientFrance
-
Maggie's Pearl, LLCActive, not recruitingPmm2-CDG | Phosphomannomutase 2 Deficiency | Phosphomannomutase 2 Congenital Disorder of Glycosylation | Phosphomannomutase II Congenital Disorder of Glycosylation | Phosphomannomutase II DeficiencyUnited States
-
Eva Morava-KoziczNot yet recruitingSLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Fatigue | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of Texas Southwestern Medical CenterRecruitingUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
University of PennsylvaniaCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of Wisconsin, MadisonTyrogenexCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Herbert Hurwitz, MDNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
Ohio State University Comprehensive Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Georgetown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Chong Kun Dang PharmaceuticalCompletedUnspecified Adult Solid Tumor, Protocol SpecificKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteAbbottCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid Tumor, Protocol Specific
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of PittsburghNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid Tumor, Protocol Specific